Are Depot Anti-psychotics Associated with Longer Persistence in Treatment Compared with Oral Antipsychotics among Patients with Schizophrenia?
Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 18, Issue 3
Abstract
Aim: Non-adherence with antipsychotics is associated with poor outcomes in patients with schizophrenia. It was anticipated that drop-out from treatment due to non-compliance with oral anti-psychotics could be abated with the use of depot antipsychotics. However previous studies are divergent regarding the association between persistence in treatment and the use of depot antipsychotics. This study aimed to compare treatment persistence among out-patients with schizophrenia receiving depot versus oral antipsychotics in Lagos, Nigeria. Methodology: Relevant clinical data of out-patients with schizophrenia (n=160) were retrieved one year post-hospitalisation at a public psychiatric facility in Nigeria. Treatment persistence (time to all cause treatment discontinuation) among the cohort of patients was determined using the Kaplan-Meier Survival analyses. Persistence in treatment between patients receiving depot versus oral antipsychotic medications alone was compared using the log rank test. Results: Nearly half (49.1%) of the cohort dropped out of treatment within one month of discharge, while 18.2% persisted for one year. There was no significant difference (p=0.727) in the mean duration of treatment persistence between patients receiving depot antipsychotics (17.4(±2.4) weeks), and those receiving oral medications alone (19.4 (±2.2) weeks). Conclusion: There is a high rate of drop-out from treatment among patients with schizophrenia, after discharge from in-patient care. Prescription of depot medications was not associated with longer persistence treatment in the studied cohort. This finding highlights the need to develop interventions to facilitate treatment persistence among patients with schizophrenia.
Authors and Affiliations
Increase Ibukun Adeosun
Keywords
Related Articles
- EP ID EP312996
- DOI 10.9734/JPRI/2017/35581
- Views 91
- Downloads 0
Anti-oxidant and Antimicrobial Flavonoid Glycosides from Alstonia boonei De Wild Leaves
Aims: Alstonia boonei De Wild (Apocynaceae) leaves are used traditionally in several parts of West Africa (including Nigeria) and Asia for the treatment of various ailments such as rheumatic and muscular pains as well as...
Performance Optimization of Sustained Release Arginine Alginate Microbeads with a Natural Polysaccharide
Objectives: The design of effective and safe novel drug delivery systems has become an integral part for the development and formulating of new medicines. So, research continuously keeps on searching for new ways to deli...
Phytochemical and Nutritional Composition Analysis of Murraya koenigii Linn Leaves
Vegetable is an indispensable constituent of human diet that supplies the body with minerals, vitamins and certain hormone precursors, in addition to protein and energy. The phytochemical and proximate analyses of Murra...
Ethnobotanical Medicinal Plants Used as Chewing Sticks among the Kenyan Communities
Background: Dental infections are among the most pursued global oral health problems. They are caused by plaque forming bacteria such as Myces, Actinobacillus, Streptococcus and Candida species which reside in the oral c...
Drying Kinetics of Gum Karaya (Sterculia urens) Using Convective Air Dryer
The present study was aimed to investigate the drying kinetics of gum karaya (S. urens). Three grades of gum (I, II, III) were dried using a cabinet-type convective dryer. Particle size equivalent to US Sieve size-6 and...